CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.75%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.32B
AUM Growth
+$155M
(+3%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
16.3%
Holding
745
New
50
Increased
312
Reduced
249
Closed
35
Top Buys
| 1 |
Kellanova
K
|
$30.1M |
| 2 |
Colgate-Palmolive
CL
|
$20M |
| 3 |
Corning
GLW
|
$19.4M |
| 4 |
Merck
MRK
|
$18.9M |
| 5 |
SPLS
Staples Inc
SPLS
|
$18M |
Top Sells
| 1 |
PepsiCo
PEP
|
$40.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$37.8M |
| 3 |
Meta Platforms (Facebook)
META
|
$23.6M |
| 4 |
Oracle
ORCL
|
$22.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$21.2M |
Sector Composition
| 1 | Healthcare | 25.58% |
| 2 | Technology | 13.64% |
| 3 | Financials | 13.2% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Communication Services | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Acadia Pharmaceuticals
ACAD
$4.26B
| $3.54M | 0.07% |
127,000
+66,000
| +108% | +$1.84M |
|
|
ZGNX
327
DELISTED
Zogenix, Inc.
ZGNX
| $3.52M | 0.07% |
243,000
| – | – |
|
328
Rogers Communications
RCI
$19.4B
| $3.52M | 0.07% |
74,649
+54,148
| +264% | +$2.55M |
|
329
Silicon Laboratories
SLAB
$4.45B
| $3.52M | 0.07% |
51,438
+2,787
| +6% | +$191K |
|
330
Public Service Enterprise Group
PEG
$40.5B
| $3.51M | 0.07% |
81,614
+47,872
| +142% | +$2.06M |
|
331
Take-Two Interactive
TTWO
$44.2B
| $3.51M | 0.07% |
+47,761
| New | +$3.51M |
|
332
ODP
ODP
$668M
| $3.49M | 0.07% |
61,872
+17,988
| +41% | +$1.01M |
|
|
MDCO
333
DELISTED
Medicines Co
MDCO
| $3.42M | 0.06% |
90,000
+13,000
| +17% | +$494K |
|
334
CSX Corp
CSX
$60.6B
| $3.42M | 0.06% |
187,968
-3,189
| -2% | -$58K |
|
|
FDC
335
DELISTED
First Data Corporation
FDC
| $3.41M | 0.06% |
187,546
-26,291
| -12% | -$478K |
|
336
State Street
STT
$32B
| $3.4M | 0.06% |
37,891
-57,742
| -60% | -$5.18M |
|
337
Ambarella
AMBA
$3.54B
| $3.4M | 0.06% |
69,994
+8,032
| +13% | +$390K |
|
|
PX
338
DELISTED
Praxair Inc
PX
| $3.38M | 0.06% |
25,484
+19,737
| +343% | +$2.62M |
|
|
STRP
339
DELISTED
Straight Path Communications Inc.
STRP
| $3.34M | 0.06% |
+18,595
| New | +$3.34M |
|
340
Marriott International Class A Common Stock
MAR
$71.9B
| $3.29M | 0.06% |
32,787
-113,856
| -78% | -$11.4M |
|
|
XLRN
341
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.28M | 0.06% |
108,000
-74,000
| -41% | -$2.25M |
|
342
S&P Global
SPGI
$164B
| $3.28M | 0.06% |
22,432
-6,912
| -24% | -$1.01M |
|
343
NetApp
NTAP
$23.7B
| $3.26M | 0.06% |
81,314
-71,247
| -47% | -$2.85M |
|
344
Esperion Therapeutics
ESPR
$540M
| $3.24M | 0.06% |
+70,000
| New | +$3.24M |
|
345
HP
HPQ
$27.4B
| $3.24M | 0.06% |
185,090
-77,419
| -29% | -$1.35M |
|
346
Truist Financial
TFC
$60B
| $3.23M | 0.06% |
71,211
+2,015
| +3% | +$91.5K |
|
347
Copart
CPRT
$47B
| $3.23M | 0.06% |
406,464
-1,092,832
| -73% | -$8.69M |
|
|
GHDX
348
DELISTED
Genomic Health, Inc.
GHDX
| $3.22M | 0.06% |
99,000
+4,000
| +4% | +$130K |
|
349
Rigel Pharmaceuticals
RIGL
$742M
| $3.22M | 0.06% |
118,000
+9,500
| +9% | +$259K |
|
350
M&T Bank
MTB
$31.2B
| $3.21M | 0.06% |
19,846
-2,295
| -10% | -$372K |
|